{"transactions":[{"id":3332193,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":152911,"kind":"person","name":"Vitolo Ottavio V.","position":1,"cik":"0001736257","reported_name":"Vitolo Ottavio V.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO"}}],"security":"Options to purchase common stock","published_at":"2019-12-23T21:53:15.000Z","date":"2019-12-19","kind":"grant","acquired":true,"shares":105000,"price":43.47,"value":4564350.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the terms of the company's 2014 Stock Option and Equity Incentive Plan, 6.25% of the options shall vest each quarter from the date of grant."}],"balance_after":105000,"derivative":{"exercise_price":43.47,"expiration_date":"2029-12-19","underlying":"Common Stock","underlying_shares":105000},"source":{"system":"sec-edgar","filing":"0001213900-19-026850","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553643/000121390019026850/ownership.xml","form_type":"4"}},{"id":3452991,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":152911,"kind":"person","name":"Vitolo Ottavio V.","position":1,"cik":"0001736257","reported_name":"Vitolo Ottavio V.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Options to purchase common stock","published_at":"2019-07-30T21:11:29.000Z","date":"2019-07-29","kind":"grant","acquired":true,"shares":150000,"price":2.2,"value":330000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the terms of the company's 2014 Stock Option and Equity Incentive Plan, 6.25% of the options shall vest each quarter from the date of grant."}],"balance_after":150000,"derivative":{"exercise_price":2.2,"expiration_date":"2029-07-29","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001213900-19-014045","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553643/000121390019014045/ownership.xml","form_type":"4"}},{"id":3723115,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":152911,"kind":"person","name":"Vitolo Ottavio V.","position":1,"cik":"0001736257","reported_name":"Vitolo Ottavio V.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Options to purchase common stock","published_at":"2018-12-20T21:57:18.000Z","date":"2018-12-20","kind":"grant","acquired":true,"shares":400000,"price":1.15,"value":460000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the terms of the company's 2014 Stock Option and Equity Incentive Plan, 6.25% of the options shall vest each quarter from the date of grant."}],"balance_after":400000,"derivative":{"exercise_price":1.15,"expiration_date":"2028-12-20","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001213900-18-017637","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553643/000121390018017637/ownership.xml","form_type":"4"}}]}